Article
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.
The Journal of clinical investigation - 17 Jun 2024
Marom Ronit, Song I-Wen, Busse Emily C, Washington Megan E, Berrier Ava S, Rossi Vittoria C, Ortinau Laura, Jeong Youngjae, Jiang Ming-Ming, Dawson Brian C, Adeyeye Mary, Leynes Carolina, Lietman Caressa D, Stroup Bridget M, Batkovskyte Dominyka, Jain Mahim, Chen Yuqing, Cela Racel, Castellon Alexis, Tran Alyssa A, Lorenzo Isabel, Meyers D Nicole, Huang Shixia, Turner Alicia, Shenava Vinitha, Wallace Maegen, Orwoll Eric, Park Dongsu, Ambrose Catherine G, Nagamani Sandesh Cs, Heaney Jason D, Lee Brendan H
Abstract excerpt
Osteogenesis imperfecta (OI) type V is the second most common form of OI, distinguished by hyperplastic callus formation and calcification of the interosseous membranes, in addition to the bone fragility. It is caused by a recurrent, dominant pathogenic variant (c.-14C>T) in interferon-induced transmembrane protein 5 (IFITM5). Here, we generated a conditional Rosa26-knockin mouse model to study the mechanistic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
